ANTIHYPERTENSIVE AGENTS NEW FINDINGS
Antihypertensives are a class of medications that are utilized to treat
hypertension (high blood pressure). Antihypertensive treatment looks to forestall the entanglements of hypertension, for example,
stroke and myocardial dead tissue. Proof proposes that decrease of the pulse by 5 mmHg can diminish the danger of
stroke by 34%, of ischemic coronary illness by 21%, and lessen the probability of dementia,
cardiovascular breakdown, and mortality from
cardiovascular disease. There are numerous classes of antihypertensives, which lower circulatory strain by various methods. Among the most significant and most generally utilized
drugs are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor opponents (ARBs), and beta blockers. Which sort of medicine to utilize at first for
hypertension has been the subject of a few huge investigations and coming about national rules. The major objective of treatment ought to be the anticipation of the significant endpoints of hypertension, for example, respiratory failure,
stroke and
cardiovascular breakdown.
High Impact List of Articles
-
Clinical risk factors associated with functional outcomes of thrombolytic therapy in stroke and non-stroke units
Meagan Reynolds, Brice Blum, Leanne Brechtel, Jordan Gainey and Thomas I Nathaniel*
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Clinical risk factors associated with functional outcomes of thrombolytic therapy in stroke and non-stroke units
Meagan Reynolds, Brice Blum, Leanne Brechtel, Jordan Gainey and Thomas I Nathaniel*
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats
Sam Mathai, Paul W. Harris, Margaret A. Brimble, Alistair J. Gunn and Jian Guan
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats
Sam Mathai, Paul W. Harris, Margaret A. Brimble, Alistair J. Gunn and Jian Guan
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Peptides targeting the mitogen-activated protein kinase pathway (JNK/Jun) fail to reduce infarct volume after permanent MCAO in Sprague Dawley rats
Cindy Si, Kym Campbell, Jane L. Cross, Paul M. Watt, Nadia Milech, Neville W. Knuckey and Bruno P. Meloni
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Peptides targeting the mitogen-activated protein kinase pathway (JNK/Jun) fail to reduce infarct volume after permanent MCAO in Sprague Dawley rats
Cindy Si, Kym Campbell, Jane L. Cross, Paul M. Watt, Nadia Milech, Neville W. Knuckey and Bruno P. Meloni
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Impact of various extents of experimental subarachnoid hemorrhage induced by the endovascular filament model on mortality and changes of cerebral blood flow
Thomas Westermaier, Alina Jauss, Giles H. Vince, Furat Raslan, Joerg Eriskat and Klaus Roosen
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Impact of various extents of experimental subarachnoid hemorrhage induced by the endovascular filament model on mortality and changes of cerebral blood flow
Thomas Westermaier, Alina Jauss, Giles H. Vince, Furat Raslan, Joerg Eriskat and Klaus Roosen
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Chronic treatment with Losartan and Cerebral Ischemic Tolerance
Zonghang Zhao, Ursula I. Tuor and Phil Barber
Research Article: Journal of Experimental Stroke & Translational Medicine
-
Chronic treatment with Losartan and Cerebral Ischemic Tolerance
Zonghang Zhao, Ursula I. Tuor and Phil Barber
Research Article: Journal of Experimental Stroke & Translational Medicine
Relevant Topics in Clinical